Your browser doesn't support javascript.
loading
Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study.
Russell, C D; Koch, O; Laurenson, I F; O'Shea, D T; Sutherland, R; Mackintosh, C L.
Afiliação
  • Russell CD; Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.
  • Koch O; Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.
  • Laurenson IF; Clinical Microbiology, Laboratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • O'Shea DT; Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.
  • Sutherland R; Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.
  • Mackintosh CL; Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK. Electronic address: Claire.L.Mackintosh@nhslothian.scot.nhs.uk.
J Hosp Infect ; 92(3): 273-9, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26810613
BACKGROUND: Hospital-acquired pneumonia (HAP) is defined as radiologically confirmed pneumonia occurring ≥48h after hospitalization, in non-intubated patients. Empirical treatment regimens use broad-spectrum antimicrobials. AIM: To evaluate the accuracy of the diagnosis of HAP and to describe the demographic and microbiological features of patients with HAP. METHODS: Medical and surgical inpatients receiving intravenous antimicrobials for a clinical diagnosis of HAP at a UK tertiary care hospital between April 2013 and 2014 were identified. Demographic and clinical details were recorded. FINDINGS: A total of 166 adult patients with a clinical diagnosis of HAP were identified. Broad-spectrum antimicrobials were prescribed, primarily piperacillin-tazobactam (57.2%) and co-amoxiclav (12.5%). Sputum from 24.7% of patients was obtained for culture. Sixty-five percent of patients had radiological evidence of new/progressive infiltrate at the time of HAP treatment, therefore meeting HAP diagnostic criteria (2005 American Thoracic Society/Infectious Diseases Society of America guidelines). Radiologically confirmed HAP was associated with higher levels of inflammatory markers and sputum culture positivity. Previous surgery and/or endotracheal intubation were associated with radiologically confirmed HAP. A bacterial pathogen was identified from 17/35 sputum samples from radiologically confirmed HAP patients. These were Gram-negative bacilli (N = 11) or Staphylococcus aureus (N = 6). Gram-negative bacteria tended to be resistant to co-amoxiclav, but susceptible to ciprofloxacin, piperacillin-tazobactam and meropenem. Five of the six S. aureus isolates were meticillin susceptible and all were susceptible to doxycycline. CONCLUSION: In ward-level hospital practice 'HAP' is an over-used diagnosis that may be inaccurate in 35% of cases when objective radiological criteria are applied. Radiologically confirmed HAP represents a distinct clinical and microbiological phenotype. Potential risk factors were identified that could represent targets for preventive interventions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Radiografia Torácica / Infecção Hospitalar / Testes Diagnósticos de Rotina / Pulmão Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / Radiografia Torácica / Infecção Hospitalar / Testes Diagnósticos de Rotina / Pulmão Idioma: En Ano de publicação: 2016 Tipo de documento: Article